Immuron’s financial position remains solid, giving it a long cash runway for its ongoing clinical trials. including the Phase 2 trial of Travelan® and the development of IMM-529, without immediate ...

Investing.com-- Most Asian stocks drifted lower on Friday, with Chinese markets sinking in anticipation of more cues on ...

Accounting for 9.2% of deaths in 2023, IHD may soon lose its place as the leading cause of death in Australia, as deaths from ...

Upstream asserts that verekitug could offer advantages over Tezpire, including potentially greater potency and longer dosing intervals. The company is testing intervals of 12 and 24 weeks in its ...

Asian shares were headed for the first weekly loss in five as the stunning rally in Chinese shares took a breather, although ...

Oil eased on Friday after a rally the previous day, but prices remained set for a second straight weekly gain as investors ...

The pharmacist who founded Australia’s first subscription-based medicinal cannabis platform, Dispensed, has been banned from ...

Investing.com-- Oil prices fell slightly in early Asian trade on Friday as stronger-than-expected U.S. inflation data sparked ...

The Self Managed Superannuation Fund (SMSF) Association and the National Farmers' Federation are calling on the Senate to reject the Australian federal government's proposed tax on superannuation ...

The ASX Group’s Monthly Activity Report for September 2024 points to a considerable decline in public listings on the ...

Prime Minister Anthony Albanese has secured a promise from China's Premier Li Qiang to lift the ban on Australian rock ...

As of September 2024, The Archive held more than 42.1 million print materials, 13 million videos, 1.2 million software programs, 14 million audio files, 5 million images, 272,660 concerts, and over ...